Commentary to "chromogranin a: biological function and clinical utility in neuroendocrine tumor disease".
作者信息
Jeske Wojciech, Glinicki Piotr, Kapuścińska Renata
出版信息
Ann Surg Oncol. 2011 Jan;18(1):293. doi: 10.1245/s10434-010-1146-5. Epub 2010 Jun 12.
Abstract
摘要
相似文献
1
Commentary to "chromogranin a: biological function and clinical utility in neuroendocrine tumor disease".《嗜铬粒蛋白A：神经内分泌肿瘤疾病中的生物学功能及临床应用》述评
Ann Surg Oncol. 2011 Jan;18(1):293. doi: 10.1245/s10434-010-1146-5. Epub 2010 Jun 12.
2
Analytical evaluation of a second generation assay for chromogranin A; a dual-site study.嗜铬粒蛋白A第二代检测方法的分析评估；一项双位点研究。
Clin Chem Lab Med. 2016 Apr;54(4):e139-42. doi: 10.1515/cclm-2015-0782.
3
Quantifying the effects of renal impairment on plasma concentrations of the neuroendocrine neoplasia biomarkers chromogranin A, chromogranin B, and cocaine- and amphetamine-regulated transcript.量化肾功能损害对神经内分泌肿瘤生物标志物嗜铬粒蛋白A、嗜铬粒蛋白B以及可卡因和苯丙胺调节转录物血浆浓度的影响。
Clin Chem. 2012 May;58(5):941-3. doi: 10.1373/clinchem.2011.176099. Epub 2012 Feb 23.
4
Chromogranin As a Biochemical Marker of Neuroendocrine Tumors.嗜铬粒蛋白作为神经内分泌肿瘤的生化标志物
Bull Exp Biol Med. 2016 Mar;160(5):702-4. doi: 10.1007/s10517-016-3254-0. Epub 2016 Mar 29.
5
Chromogranin A--biological function and clinical utility in neuro endocrine tumor disease.嗜铬粒蛋白 A——神经内分泌肿瘤疾病中的生物学功能和临床应用。
Ann Surg Oncol. 2010 Sep;17(9):2427-43. doi: 10.1245/s10434-010-1006-3. Epub 2010 Mar 9.
6
Re: Biological variation of neuroendocrine tumor markers chromogranin A and neuron-specific enolase.关于：神经内分泌肿瘤标志物嗜铬粒蛋白A和神经元特异性烯醇化酶的生物学变异
Clin Biochem. 2013 Aug;46(12):1145. doi: 10.1016/j.clinbiochem.2013.04.010. Epub 2013 Apr 19.
7
Comparison of the utility of Cocaine- and Amphetamine-Regulated Transcript (CART), chromogranin A, and chromogranin B in neuroendocrine tumor diagnosis and assessment of disease progression.可卡因和苯丙胺调节转录物（CART）、嗜铬粒蛋白A和嗜铬粒蛋白B在神经内分泌肿瘤诊断及疾病进展评估中的效用比较。
J Clin Endocrinol Metab. 2015 Apr;100(4):1520-8. doi: 10.1210/jc.2014-3640. Epub 2015 Feb 9.
8
Diagnostic value of chromogranin A in pancreatic neuroendocrine tumors depends on tumor size: A prospective observational study from a single institute.嗜铬粒蛋白A在胰腺神经内分泌肿瘤中的诊断价值取决于肿瘤大小：一项来自单一机构的前瞻性观察研究。
Surgery. 2017 Jul;162(1):120-130. doi: 10.1016/j.surg.2017.01.019. Epub 2017 Mar 2.
9
10
Blood Chromogranin A Is Not Effective as a Biomarker for Diagnosis or Management of Bronchopulmonary Neuroendocrine Tumors/Neoplasms.血嗜铬粒蛋白 A 作为支气管肺神经内分泌肿瘤/肿瘤的诊断或治疗标志物并不有效。
Neuroendocrinology. 2020;110(3-4):185-197. doi: 10.1159/000500202. Epub 2019 Apr 16.
本文引用的文献
1
2
Chromogranin A--biological function and clinical utility in neuro endocrine tumor disease.嗜铬粒蛋白 A——神经内分泌肿瘤疾病中的生物学功能和临床应用。
Ann Surg Oncol. 2010 Sep;17(9):2427-43. doi: 10.1245/s10434-010-1006-3. Epub 2010 Mar 9.
3
Validation of serum versus plasma measurements of chromogranin a levels in patients with carcinoid tumors: lack of correlation between absolute chromogranin a levels and symptom frequency.类癌肿瘤患者血清与血浆嗜铬粒蛋白A水平测量的验证：嗜铬粒蛋白A绝对水平与症状频率之间缺乏相关性。
Pancreas. 2006 Oct;33(3):250-4. doi: 10.1097/01.mpa.0000235302.73615.d4.
Zotero 插件